|10-13-2018 03:30 PM CET - IT, New Media & Software||
Artificial Intelligence in Medicine Market by Top Key Participant Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals
Press release from: Research Beam
Artificial Intelligence in Medicine Market by Product Type (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), and Application (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025
The global artificial intelligence (AI) in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. AI is an intelligent system that applies various human intelligence-based functions such as reasoning, learning, and problem-solving skills. AI technology uses software and different algorithms in the field of pharmaceuticals to support the decision-making processes for existing drugs and repurposing drugs to treat other conditions, along with accelerating the clinical trials process by finding the right patients from several data sources.
Request Sample copy of this Report @ www.researchbeam.com/artificial-intelligence-in-medicine-...
Shortage of skilled healthcare professionals and increase in the processing power of AI systems that is projected to help improve the efficiency of drug discovery and management of clinical trials majorly drive the growth of the global artificial intelligence in medicine market. Furthermore, the growth in importance of precision medicine and rise in funding of the R&D activities for the use of AI technology in the field of medicine are expected to fuel the market growth. However, limited acceptance from healthcare professionals and limitations of AI decision-making can impede the market growth. Untapped market opportunities available in developing regions such as India and China help to open new avenues for the growth of the artificial intelligence in medicine market in future.
The global artificial intelligence in medicine market is segmented based on product type, technology, application, and region. Based on product type, the market is segmented into hardware, software, and service. Based on technology, the market is classified into deep learning, querying method, natural language processing, and context aware processing. Based on application, the market is categorized into drug discovery & repurposing, clinical research trial, personalized medicine, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
• Market estimations are based on comprehensive analysis of the key developments in the industry.
• The global market is comprehensively analyzed with respect to product type, technology, application, and region.
• In-depth analysis based on region assists to understand the regional market to help in strategic business planning.
• The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Request discount of this Report : @ www.researchbeam.com/artificial-intelligence-in-medicine-...
Market Segment by Manufacturers, this report covers – Welltok, Inc., Intel Corporation, Nvidia Corporation, Google Inc., IBM Corporation, Microsoft Corporation, General Vision, Inc., Enlitic, Inc., BioXcel Corporation, Berg Health, InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, Recursion Pharmaceuticals
KEY MARKET SEGMENTS
By Product Type
• Deep Learning
• Querying Method
• Natural Language Processing
• Context Aware Processing
• Drug Discovery & Repurposing (Preclinical Phase)
• Clinical Research Trial
• Personalized Medicine
More Report At: www.researchbeam.com/artificial-intelligence-in-medicine-...
Market Segment by Table of Contents:
1 Artificial Intelligence in Medicine Market Overview
1.1 Product Overview and Scope of Artificial Intelligence in Medicine
1.2 Classification of Artificial Intelligence in Medicine by Types
1.2.1 Global Artificial Intelligence in Medicine Revenue Comparison by Types (2017-2023)
1.2.2 Global Artificial Intelligence in Medicine Revenue Market Share by Types in 2017
1.3 Global Artificial Intelligence in Medicine Market by Application
1.3.1 Global Artificial Intelligence in Medicine Market Size and Market Share Comparison by Applications (2013-2023)
1.3.3 Government and Defense
1.4 Global Artificial Intelligence in Medicine Market by Regions
1.4.1 Global Artificial Intelligence in Medicine Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Artificial Intelligence in Medicine Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Artificial Intelligence in Medicine Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Intelligence in Medicine Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Artificial Intelligence in Medicine Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Intelligence in Medicine Status and Prospect (2013-2023)
1.5 Global Market Size of Artificial Intelligence in Medicine (2013-2023)
Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
+1 (800) 910-6452
This release was published on openPR.
News-ID: 1301686 • Views: 862More releases